Loading university
Benoit Roux — Dr. Benoit Roux's research lab at the University of Chicago focuses on using molecular dynamics simulations to investigate how potassium (Kv) and sodium (Nav) channels function within biological membranes. The lab aims to understand the complex interactions that influence ion channel behavior, particularly in relation to neurological disorders and cardiac functions. By improving computational models, the lab seeks to explore the fundamental forces that guide ion permeation and channel activation, which are critical for human health.
Ralph R Weichselbaum — Dr. Ralph Weichselbaum's lab at the University of Chicago focuses on innovative cancer therapies using genetically-engineered bacteria. They specifically study how Bifidobacteria can be used to enhance treatment for challenging cancers like pancreatic cancer by improving the immune response and working synergistically with traditional therapies like radiation. The lab is pioneering in engineering these bacteria to precisely deliver therapeutic agents to tumors, potentially changing how we treat hard-to-reach cancers.
Gregory A. Voth — Dr. Gregory A. Voth's lab focuses on using advanced computer simulations to better understand complex biological processes, specifically related to HIV-1 and cellular mechanics. By modeling how proteins interact with cell membranes and each other, the lab aims to uncover vital steps in the life cycle of the HIV virus and the mechanisms that allow cells to move and interact. This research has implications for developing new treatments for diseases related to HIV and cellular dysfunction.
Thomas F Gajewski — Dr. Thomas F Gajewski's lab focuses on improving cancer immunotherapy treatments by investigating why some patients do not respond to anti-PD-1 therapies. By studying the immune environment of tumors and the genetics involved, the lab aims to discover new ways to enhance the effectiveness of these therapies. The research combines insights from clinical samples and mouse models to explore various avenues for boosting anti-tumor immune responses.
Carole Ober — Dr. Carole Ober's lab at the University of Chicago focuses on understanding asthma and allergic diseases, which affect many people around the world. The lab aims to identify genetic factors that contribute to these diseases and to explore how they impact different types of immune cells in the body. By doing this research, they hope to uncover new drug targets that can lead to better treatments for patients.
Jun Huang — Jun Huang's lab at the University of Chicago focuses on developing innovative treatments for Alzheimer's Disease (AD) using advanced biotechnology. The lab is exploring how to engineer microglia, the brain's immune cells, to more effectively clear harmful amyloid-beta plaques associated with AD. Their work aims to create microglia that can recognize and degrade these plaques to help slow the disease's progression.
Tao Pan — Dr. Tao Pan's lab at the University of Chicago focuses on understanding small nucleolar RNAs (snoRNAs), which are important molecules that help guide modifications in ribosomal RNA and can influence gene expression. By using advanced sequencing technologies, the lab aims to uncover the roles and interactions of these snoRNAs in human cells and how they impact various biological processes and diseases. This work could provide new insights into genome regulation and RNA-based therapies.
Matthew Tirrell — Dr. Matthew Tirrell's lab at the University of Chicago focuses on using targeted nanomedicine to address serious lung diseases like acute respiratory distress syndrome (ARDS) and pulmonary fibrosis. Their innovative approach seeks to modify specific cell types during different phases of lung disease, particularly in response to viral infections such as COVID-19. The lab aims to develop new therapies that can effectively reduce lung injury and fibrosis, offering hope for improved treatment options in the future.
S. Murray Sherman — Dr. S. Murray Sherman's lab at the University of Chicago focuses on the interactions between the thalamus and the cortex in the brain, specifically how these structures communicate to influence sensory processing and cognitive functions. The research aims to uncover the role of lesser-known thalamic nuclei in the flow of information across cortical areas, which could provide insights into cognitive disorders such as schizophrenia and Alzheimer's disease.